CLINICAL FEATURES OF SEVERE INFANT ATOPIC DERMATITIS WITH HYPOPROTEINEMIA

DOI Web Site 5 Citations 18 References
  • Akashi Masayuki
    Division of Allergy, National Center for Child Health and Development
  • Nomura Ichiro
    Division of Allergy, National Center for Child Health and Development
  • Saito Akemi
    Division of Allergy, National Center for Child Health and Development
  • Narita Masami
    Division of Allergy, National Center for Child Health and Development
  • Suda Tomoko
    Division of Allergy, National Center for Child Health and Development
  • Akasawa Akira
    Department of Interdisciplinary Medicine, National Center for Child Health and Development
  • Ohya Yukihiro
    Division of Allergy, National Center for Child Health and Development

Bibliographic Information

Other Title
  • 低蛋白血症を伴った乳児重症アトピー性皮膚炎についての検討
  • テイタンパク ケツショウ オ トモナッタ ニュウジ ジュウショウ アトピーセイ ヒフエン ニ ツイテ ノ ケントウ

Search this article

Description

Objective: In recent years, there have been sporadic reports of severe atopic dermatitis (AD) with hypoproteinemia and growth impairment. The present study was conduced in order to ascertain the characteristics of patients with severe infant AD with hypoproteinemia at the initial visit and their treatment courses. Subjects: Of AD patients younger than 1 year of age who visited the department over a 27-month period from March 2002, subjects were those with severe AD accompanied by hypoproteinemia. The clinical characteristics of these patients at the initial visit and the changes in symptoms and laboratory findings were statistically analyzed. Results: Of the total of 119 AD patients younger than 1 year of age visited to the department during the above-mentioned period, 15 patients had severe AD with hypoproteinemia. The height and body weight of approximately half of the patients were less than 3rd percentile, and 10% and more of the patients had severe hyponatremia or hyperpotassemia. The platelet count for 60% of the patients exceeded 800×10^3/μl. After visiting the department therapy involving the use of skin care products and topical steroids and the removal of exacerbation factors quickly improved dermal symptoms and laboratory findings. Conclusion: Severe AD is a disease that should be cautiously treated because of the risk of hypoproteinemia, growth impairment, electrolyte abnormalities, and thrombocytosis; however, it should be noted that appropriate treatments can improve this condition.

Journal

Citations (5)*help

See more

References(18)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top